)
Visual
test
China Traditional Chinese Medicine
China Traditional Chinese Medicine (570) investor relations material
China Traditional Chinese Medicine H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary1 Sep, 2025
Executive summary
Revenue for the six months ended 30 June 2025 was RMB7,463.4 million, down 11.0% year-over-year, mainly due to increased centralised procurement, intensified competition, and strategic business adjustments.
Gross profit decreased by 10.5% to RMB3,634.6 million, but gross margin improved slightly to 48.7% due to sales structure optimization.
Net loss for the period was RMB141.8 million, compared to a profit of RMB214.1 million in the prior year, mainly due to lower sales, goodwill impairment, and increased credit loss provisions.
No interim dividend was declared for the period.
Financial highlights
Revenue: RMB7,463.4 million (down 11.0% year-over-year).
Gross profit: RMB3,634.6 million (down 10.5% year-over-year); gross margin: 48.7% (up 0.3pp).
Net loss: RMB141.8 million (net margin -1.9%), compared to net profit of RMB214.1 million (net margin 2.6%) last year.
Basic EPS: -2.14 RMB cents, down from 4.19 RMB cents.
Operating cash flow: RMB924.9 million (up from RMB569.7 million).
Outlook and guidance
The company plans to optimize its business structure, focus on value creation, and enhance cost control and efficiency.
Emphasis on technological innovation, digital transformation, and supply chain resilience to adapt to policy and market changes.
The company will respond proactively to policy changes and market competition, aiming to build a leading TCM industrial cluster.
What drove Jiangyin Tianjiang goodwill impairment?
How did centralized procurement impact CTCMG profit?
What business lines were optimized or suspended?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next China Traditional Chinese Medicine earnings date
H2 202525 Mar, 2026
China Traditional Chinese Medicine
Next China Traditional Chinese Medicine earnings date
H2 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
China Traditional Chinese Medicine Holdings Co. Limited is engaged in the research, production, and distribution of traditional Chinese medicines. The company focuses on manufacturing a wide range of herbal medicines and health products, leveraging traditional Chinese medicinal practices combined with modern pharmaceutical technologies. Its product portfolio spans various therapeutic areas, providing treatments for respiratory, cardiovascular, gastrointestinal, and orthopedic health, among others. China Traditional Chinese Medicine Holdings operates through its network of production facilities, retail pharmacies, and distribution channels, serving markets primarily in China and select international regions. The company is headquartered in Foshan, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage